Advanced Practice Midwife in Henderson, NV Accepting Medicare
2 Advanced Practice Midwife nurses found. Showing 1 - 2
 Marsha A Brown, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 10001 S Eastern Ave, Suite 309, Henderson, NV 89052 Phone: 702-269-6345 |
Kaonoulu P. Madela, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 891 Harbor Ave, Henderson, NV 89002 Phone: 702-696-8423 |
News Archive
Britain too laid back about bird flu
Despite the fact that France's first-known case of the deadly H5N1 strain of avian flu was found in a duck which is a winter migrant to Ireland and western Britain from Russia and Eastern Europe, authorities in the UK appear to have no immediate plans to order Britain's 25 million free-range chickens to be kept indoors.
Cardinal Wuerl says bishops are united in fight with administration over contraception rule
Cardinal Donald Wuerl, the archbishop of Washington, on Sunday denied a split among Catholic bishops about the lawsuit challenging the Obama administration's rule mandating that employers and health insurance plans cover contraception. "I have yet to see among the bishops any split at all," Wuerl said on "Fox News Sunday." "The bishop who was quoted saying he was concerned issued a statement saying that was not his position."
Study suggests sewer rats immune to SARS-CoV-2
Although the researchers found that the rats tested negative for the virus, they say it is important to continue monitoring animals for the virus as it mutates, making previously resistant species susceptible to infection.
Short-term exposure to air pollution increases risk of heart failure
Short-term exposure to most major air pollutants appears to increase the risk of being hospitalised for and dying from heart failure, according to a systematic review and meta-analysis of data from 12 countries published in The Lancet.
Amylin Pharmaceuticals and Takeda Pharmaceutical to advance pramlintide/metreleptin combination therapy development
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced today that the companies have selected the combination treatment of pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, for advancement toward Phase 3 development. The decision to advance the program followed encouraging results from a 52-week blinded, placebo-controlled Phase 2 extension study. The pramlintide/metreleptin combination met the key target criteria of sustained and robust weight loss.
› Verified 2 days ago